GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Nihon Chouzai Co Ltd (TSE:3341) » Definitions » Research & Development

Nihon Chouzai Co (TSE:3341) Research & Development : 円0 Mil (TTM As of Sep. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Nihon Chouzai Co Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Nihon Chouzai Co's Research & Development for the three months ended in Sep. 2024 was 円0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2024 was 円0 Mil.

Nihon Chouzai Co Research & Development Historical Data

The historical data trend for Nihon Chouzai Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nihon Chouzai Co Research & Development Chart

Nihon Chouzai Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Nihon Chouzai Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Nihon Chouzai Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nihon Chouzai Co  (TSE:3341) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Nihon Chouzai Co Research & Development Related Terms

Thank you for viewing the detailed overview of Nihon Chouzai Co's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Nihon Chouzai Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Nihon Chouzai Co Ltd (TSE:3341) » Definitions » Research & Development
Comparable Companies
TSE:7679 TSE:3034 TSE:2664 TSE:4350 TSE:3544 TSE:3417 TSE:2934 TSE:2796 TSE:9776 TSE:7129 HKSE:06618 WBA HKSE:00241 BSP:RADL3 TSE:3088 JSE:CLS SAU:4164 SHSE:603939 SHSE:600998 TSE:3349
Traded in Other Exchanges
N/A
Address
Sapporo Odori Nishi Front Park 8 floors 7-1, Tokyo, JPN
Website
http://www.nicho.co.jp
Nihon Chouzai Co Ltd operates in the pharmaceutical industry. The company is organized into segments: Pharmacy, Pharmaceutical Manufacturing and Sales, and Healthcare Staffing Services and operates mainly from Japan. Through its operating segments, the firm manages a chain of pharmacies nationwide, manufactures and sells generic drugs, and provides staffing services that are specialized in pharmacy.

Nihon Chouzai Co Headlines

No Headlines